A Pilot Study of Telmisartan (Micardis) for the Prevention of Acute Graft Versus Host Disease Post Allogeneic Hematopoietic Stem Cell Transplantation

Type of Cancer

Phase

Division (Location)

Study ID

NCT#

Brief Description
A Pilot Study of Telmisartan (Micardis) for the Prevention of Acute Graft Versus Host Disease Post Allogeneic Hematopoietic Stem Cell Transplantation

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.